Baroldi Joseph — SEC Form 4 filings
SEC reporting owner CIK 1813775. 18 Form 4 filings on record with FilingPulse; latest filed 2026-06-30.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2024-01-17 to 2026-06-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 23 legs across 15 filings — 108,904 shares, $6,930,600 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 57.
- Largest priced transaction: sale of 30,000 shares @ $59.09 ($1,772,592) in IONIS PHARMACEUTICALS INC, filed 2025-09-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC (IONS) | EVP, Chief Business Officer | 18 | — | 23 legs · 108,904 sh · $6,930,600 | 57 |
Form 4 filings — Baroldi Joseph
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-30 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 3,866 @ $56.78 · Option exercise (M): 1,769 @ $32.60 · Sale (S): 5,635 @ $80.16 · Option exercise (M): 1,769 (derivative) @ $0 · Option exercise (M): 3,866 (derivative) @ $0 | EDGAR |
| 2026-04-30 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 1,626 @ $71.79 | EDGAR |
| 2026-04-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 10,837 @ $0 · Sale (S): 5,619 @ $74.56 · Option exercise (M): 10,837 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 4,096 @ $79.36 · Option exercise (M): 820 @ $56.78 · Option exercise (M): 879 @ $32.60 · Sale (S): 2,088 @ $80.41 · Sale (S): 36 @ $81.01 · Option exercise (M): 238 @ $56.78 · +7 more | EDGAR |
| 2026-02-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 10,278 @ $0 · Sale (S): 5,296 @ $82.96 | EDGAR |
| 2026-01-20 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 17,037 @ $0 · Sale (S): 6,907 @ $75.75 · Option exercise (M): 2,850 @ $0 · Sale (S): 1,149 @ $75.78 · Grant/award (A): 25,800 (derivative) @ $0 · Option exercise (M): 17,037 (derivative) @ $0 · +3 more | EDGAR |
| 2026-01-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 19,350 (derivative) @ $0 · Grant/award (A): 2,600 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 1,625 @ $69.37 | EDGAR |
| 2025-10-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 15,000 @ $31.80 · Sale (S): 15,000 @ $68.01 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 11,950 @ $31.80 · Sale (S): 11,950 @ $62.16 · Option exercise (M): 11,950 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 250 @ $31.80 · Sale (S): 250 @ $62 · Option exercise (M): 250 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 2,800 @ $31.80 · Sale (S): 2,800 @ $62.01 · Option exercise (M): 15,000 @ $31.80 · Sale (S): 30,000 @ $59.09 · Option exercise (M): 15,000 @ $31.80 · Option exercise (M): 2,800 (derivative) @ $0 · +2 more | EDGAR |
| 2025-04-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 10,837 @ $0 · Sale (S): 3,928 @ $28.40 · Option exercise (M): 10,837 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 8,787 @ $0 · Sale (S): 3,401 @ $32.70 · Option exercise (M): 2,460 @ $0 · Sale (S): 1,029 @ $32.70 · Grant/award (A): 22,000 (derivative) @ $0 · Grant/award (A): 33,000 (derivative) @ $0 · +3 more | EDGAR |
| 2025-01-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 22,000 (derivative) @ $0 · Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 10,838 @ $0 · Sale (S): 4,006 @ $41.60 · Option exercise (M): 10,838 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 3,688 @ $0 · Sale (S): 1,460 @ $50.42 · Option exercise (M): 1,353 @ $0 · Sale (S): 564 @ $50.42 · Option exercise (M): 3,688 (derivative) @ $0 · Option exercise (M): 1,353 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 17,000 (derivative) @ $0 · Grant/award (A): 20,400 (derivative) @ $0 · Grant/award (A): 1,800 (derivative) @ $0 · Grant/award (A): 2,625 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1813775 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →